Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors

被引:275
作者
Kim, CU
Lew, W
Williams, MA
Wu, HW
Zhang, LJ
Chen, XW
Escarpe, PA
Mendel, DB
Laver, WG
Stevens, RC
机构
[1] Gilead Sci Inc, Foster City, CA 94404 USA
[2] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 260, Australia
[3] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA
关键词
D O I
10.1021/jm980162u
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of influenza neuraminidase inhibitors with the cyclohexene scaffold containing lipophilic side chains have been synthesized anti evaluated for influenza A and B neuraminidase inhibitory activity. The size and geometry of side chains have been modified systematically in order to investigate structure-activity relationships of this class of compounds. The X-ray crystal structures of several analogues complexed with neuraminidase revealed that the lipophilic side chains bound to the hydrophobic pocket consisted of Glu276, Ala246, Arg224, and Ile222 of the enzyme active site. The structure-activity relationship studies of this series have also demonstrated remarkably different inhibitory potency between influenza A and B neuraminidase. This indicated that the lipophilic side chains had quite different hydrophobic interactions with influenza A and B neuraminidase despite their complete homology in the active site. Influenza B neuraminidase appeared to be much more sensitive toward the increased steric bulkiness of inhibitors compared to influenza A neuraminidase. From the extensive structure-activity relationship investigation reported in this article, GS 4071 emerged as one of the most potent influenza neuraminidase inhibitors against both influenza A and B strains.
引用
收藏
页码:2451 / 2460
页数:10
相关论文
共 28 条
  • [1] BELPAIRE FM, 1996, PRACTICE MED CHEM FA, P596
  • [2] BRUNGER AT, 1993, XPLDR 3 1 SOFTWARE
  • [3] EVIDENCE FOR A SIALOSYL CATION TRANSITION-STATE COMPLEX IN THE REACTION OF SIALIDASE FROM INFLUENZA-VIRUS
    CHONG, AKJ
    PEGG, MS
    TAYLOR, NR
    VONITZSTEIN, M
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 207 (01): : 335 - 343
  • [4] Colman P.M., 1989, INFLUENZA VIRUSES, P175
  • [5] INFLUENZA-VIRUS NEURAMINIDASE - STRUCTURE, ANTIBODIES, AND INHIBITORS
    COLMAN, PM
    [J]. PROTEIN SCIENCE, 1994, 3 (10) : 1687 - 1696
  • [6] FILLER R, 1982, BIOMEDICAL ASPECTS F, P1
  • [7] Fromtling Robert A., 1996, Drugs of the Future, V21, P375
  • [8] Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections
    Hayden, FG
    Osterhaus, ADME
    Treanor, JJ
    Fleming, DM
    Aoki, FY
    Nicholson, KG
    Bohnen, AM
    Hirst, HM
    Keene, O
    Wightman, K
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (13) : 874 - 880
  • [9] HAYDEN FG, 1997, 37 ICAAC LAT BREAK S
  • [10] An information theory model of hydrophobic interactions
    Hummer, G
    Garde, S
    Garcia, AE
    Pohorille, A
    Pratt, LR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (17) : 8951 - 8955